Global and Regional PET Radiopharmaceuticals Market Details Research Report 2021-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global PET Radiopharmaceuticals Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive PET Radiopharmaceuticals market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global PET Radiopharmaceuticals market.

    By Player:

    • Bracco Imaging SpA (Italy)

    • GE Healthcare (UK)

    • Nordion Inc (Canada)

    • Lantheus Medical Imaging Inc (US)

    • Mallinckrodt plc (Ireland)

    • Cardinal Health Inc (US)

    • IBA Molecular Imaging (Belgium)

    • Advanced Accelerator Applications SA (France)

    • Eczacibasi-Monrol Nuclear Products (Turkey)

    • Bayer AG (Germany)

    By Type:

    • F-18

    • Ru-82

    • Others

    By End-User:

    • Oncology

    • Cardiology

    • Neurology

    • Others

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 PET Radiopharmaceuticals Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global PET Radiopharmaceuticals Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global PET Radiopharmaceuticals Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global PET Radiopharmaceuticals Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global PET Radiopharmaceuticals Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers PET Radiopharmaceuticals Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Bracco Imaging SpA (Italy)

      • 3.1.1 Bracco Imaging SpA (Italy) - Company Business Overview

      • 3.1.2 Bracco Imaging SpA (Italy) - Company Financial Performance

      • 3.1.3 Bracco Imaging SpA (Italy) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.1.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 GE Healthcare (UK)

      • 3.2.1 GE Healthcare (UK) - Company Business Overview

      • 3.2.2 GE Healthcare (UK) - Company Financial Performance

      • 3.2.3 GE Healthcare (UK) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.2.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Nordion Inc (Canada)

      • 3.3.1 Nordion Inc (Canada) - Company Business Overview

      • 3.3.2 Nordion Inc (Canada) - Company Financial Performance

      • 3.3.3 Nordion Inc (Canada) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.3.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Lantheus Medical Imaging Inc (US)

      • 3.4.1 Lantheus Medical Imaging Inc (US) - Company Business Overview

      • 3.4.2 Lantheus Medical Imaging Inc (US) - Company Financial Performance

      • 3.4.3 Lantheus Medical Imaging Inc (US) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.4.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Mallinckrodt plc (Ireland)

      • 3.5.1 Mallinckrodt plc (Ireland) - Company Business Overview

      • 3.5.2 Mallinckrodt plc (Ireland) - Company Financial Performance

      • 3.5.3 Mallinckrodt plc (Ireland) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.5.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Cardinal Health Inc (US)

      • 3.6.1 Cardinal Health Inc (US) - Company Business Overview

      • 3.6.2 Cardinal Health Inc (US) - Company Financial Performance

      • 3.6.3 Cardinal Health Inc (US) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.6.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 IBA Molecular Imaging (Belgium)

      • 3.7.1 IBA Molecular Imaging (Belgium) - Company Business Overview

      • 3.7.2 IBA Molecular Imaging (Belgium) - Company Financial Performance

      • 3.7.3 IBA Molecular Imaging (Belgium) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.7.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 Advanced Accelerator Applications SA (France)

      • 3.8.1 Advanced Accelerator Applications SA (France) - Company Business Overview

      • 3.8.2 Advanced Accelerator Applications SA (France) - Company Financial Performance

      • 3.8.3 Advanced Accelerator Applications SA (France) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.8.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 Eczacibasi-Monrol Nuclear Products (Turkey)

      • 3.9.1 Eczacibasi-Monrol Nuclear Products (Turkey) - Company Business Overview

      • 3.9.2 Eczacibasi-Monrol Nuclear Products (Turkey) - Company Financial Performance

      • 3.9.3 Eczacibasi-Monrol Nuclear Products (Turkey) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.9.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Bayer AG (Germany)

      • 3.10.1 Bayer AG (Germany) - Company Business Overview

      • 3.10.2 Bayer AG (Germany) - Company Financial Performance

      • 3.10.3 Bayer AG (Germany) - Company Financial Performance of PET Radiopharmaceuticals

      • 3.10.4 PET Radiopharmaceuticals Product Benchmarking

      • 3.10.5 Strategic Initiatives

    4 Global PET Radiopharmaceuticals Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global PET Radiopharmaceuticals Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of F-18 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Ru-82 2016-2021

      • 4.2.3 Global Revenue and Growth Rate of Others 2016-2021

    • 4.3 Global PET Radiopharmaceuticals Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of F-18 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Ru-82 2016-2021

      • 4.3.3 Global Sales and Growth Rate of Others 2016-2021

    • 4.4 Global PET Radiopharmaceuticals Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global PET Radiopharmaceuticals Market Sales and Market Share by Types (Forecast)

    • 4.6 Global PET Radiopharmaceuticals Market Price By Type from 2016 to 2026

    5 Global PET Radiopharmaceuticals Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of PET Radiopharmaceuticals

    • 5.2 Global PET Radiopharmaceuticals Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Oncology 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Cardiology 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Neurology 2016-2021

      • 5.2.4 Global Revenue and Growth Rate of Others 2016-2021

    • 5.3 Global PET Radiopharmaceuticals Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Oncology 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Cardiology 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Neurology 2016-2021

      • 5.3.4 Global Sales and Growth Rate of Others 2016-2021

    • 5.4 Global PET Radiopharmaceuticals Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global PET Radiopharmaceuticals Market Sales and Market Share by Application (Forecast)

    6 Global PET Radiopharmaceuticals Market Segment Analysis (Geography Level)

    • 6.1 Global PET Radiopharmaceuticals Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global PET Radiopharmaceuticals Market Sales and Market Share by Geography (Historical)

    • 6.3 Global PET Radiopharmaceuticals Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global PET Radiopharmaceuticals Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in PET Radiopharmaceuticals Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in PET Radiopharmaceuticals Market from 2016 to 2020

    7. North America PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 7.1 North America PET Radiopharmaceuticals Market Segment by Countries

      • 7.1.1 North America PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 7.1.2 North America PET Radiopharmaceuticals Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 7.3 North America PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe PET Radiopharmaceuticals Market Segment by Countries

      • 8.1.1 Europe PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 8.1.2 Europe PET Radiopharmaceuticals Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 8.3 Europe PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia PET Radiopharmaceuticals Market Segment by Countries

      • 9.1.1 Asia PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 9.1.2 Asia PET Radiopharmaceuticals Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 9.3 Asia PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 10.1 South America PET Radiopharmaceuticals Market Segment by Countries

      • 10.1.1 South America PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 10.1.2 South America PET Radiopharmaceuticals Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 10.3 South America PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East PET Radiopharmaceuticals Market Segment by Countries

      • 11.1.1 Middle East PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 11.1.2 Middle East PET Radiopharmaceuticals Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 11.3 Middle East PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa PET Radiopharmaceuticals Market Segment by Countries

      • 12.1.1 Africa PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 12.1.2 Africa PET Radiopharmaceuticals Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 12.3 Africa PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania PET Radiopharmaceuticals Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania PET Radiopharmaceuticals Market Segment by Countries

      • 13.1.1 Oceania PET Radiopharmaceuticals Market Revenue Segment by Countries

      • 13.1.2 Oceania PET Radiopharmaceuticals Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania PET Radiopharmaceuticals Market Segment (Product Type Level)

    • 13.3 Oceania PET Radiopharmaceuticals Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 PET Radiopharmaceuticals Production Analysis

      • 14.2.1 Manufacturing Cost Structure of PET Radiopharmaceuticals

      • 14.2.2 Manufacturing Process Analysis of PET Radiopharmaceuticals

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of PET Radiopharmaceuticals Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 PET Radiopharmaceuticals Industry Market Status, Pre-COVID-19

      • 15.5.3 PET Radiopharmaceuticals Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 PET Radiopharmaceuticals Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure PET Radiopharmaceuticals Product Picture

    • Table PET Radiopharmaceuticals Product Definition

    • Table Study Scope by Types

    • Figure Global PET Radiopharmaceuticals Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global PET Radiopharmaceuticals Market Value by Application (2016 - 2026)

    • Figure Global PET Radiopharmaceuticals Market Size and Growth Rate from 2016 to 2026

    • Table Global PET Radiopharmaceuticals Production Capacity by Manufacturers (2016-2021)

    • Table Global PET Radiopharmaceuticals Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global PET Radiopharmaceuticals Revenue by Manufacturers (2016-2021)

    • Table Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers PET Radiopharmaceuticals Plant Distribution and Sales Country

    • Table Bracco Imaging SpA (Italy) - Company Business Overview

    • Figure Bracco Imaging SpA (Italy) Total Revenue from 2018 to 2020

    • Table Bracco Imaging SpA (Italy) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bracco Imaging SpA (Italy) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Bracco Imaging SpA (Italy)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table GE Healthcare (UK) - Company Business Overview

    • Figure GE Healthcare (UK) Total Revenue from 2018 to 2020

    • Table GE Healthcare (UK) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure GE Healthcare (UK) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of GE Healthcare (UK)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Nordion Inc (Canada) - Company Business Overview

    • Figure Nordion Inc (Canada) Total Revenue from 2018 to 2020

    • Table Nordion Inc (Canada) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Nordion Inc (Canada) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Nordion Inc (Canada)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Lantheus Medical Imaging Inc (US) - Company Business Overview

    • Figure Lantheus Medical Imaging Inc (US) Total Revenue from 2018 to 2020

    • Table Lantheus Medical Imaging Inc (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Lantheus Medical Imaging Inc (US) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging Inc (US)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Mallinckrodt plc (Ireland) - Company Business Overview

    • Figure Mallinckrodt plc (Ireland) Total Revenue from 2018 to 2020

    • Table Mallinckrodt plc (Ireland) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Mallinckrodt plc (Ireland) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt plc (Ireland)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Cardinal Health Inc (US) - Company Business Overview

    • Figure Cardinal Health Inc (US) Total Revenue from 2018 to 2020

    • Table Cardinal Health Inc (US) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Cardinal Health Inc (US) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Cardinal Health Inc (US)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table IBA Molecular Imaging (Belgium) - Company Business Overview

    • Figure IBA Molecular Imaging (Belgium) Total Revenue from 2018 to 2020

    • Table IBA Molecular Imaging (Belgium) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure IBA Molecular Imaging (Belgium) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of IBA Molecular Imaging (Belgium)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Advanced Accelerator Applications SA (France) - Company Business Overview

    • Figure Advanced Accelerator Applications SA (France) Total Revenue from 2018 to 2020

    • Table Advanced Accelerator Applications SA (France) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Advanced Accelerator Applications SA (France) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications SA (France)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) - Company Business Overview

    • Figure Eczacibasi-Monrol Nuclear Products (Turkey) Total Revenue from 2018 to 2020

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Eczacibasi-Monrol Nuclear Products (Turkey) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Eczacibasi-Monrol Nuclear Products (Turkey)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Bayer AG (Germany) - Company Business Overview

    • Figure Bayer AG (Germany) Total Revenue from 2018 to 2020

    • Table Bayer AG (Germany) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Bayer AG (Germany) Sales and Growth Rate Analysis of PET Radiopharmaceuticals

    • Figure Revenue and Market Share Analysis of Bayer AG (Germany)

    • Table PET Radiopharmaceuticals Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global PET Radiopharmaceuticals Market Revenue by Types (Historical)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of F-18 2016-2021

    • Figure Global Revenue and Growth Rate of Ru-82 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global PET Radiopharmaceuticals Market Sales by Types (Historical)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of F-18 2016-2021

    • Figure Global Sales and Growth Rate of Ru-82 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global PET Radiopharmaceuticals Market Revenue by Types (Forecast)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Types (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales by Types (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Types (Forecast)

    • Figure Global PET Radiopharmaceuticals Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for PET Radiopharmaceuticals

    • Table Global PET Radiopharmaceuticals Market Revenue by Application (Historical)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Oncology 2016-2021

    • Figure Global Revenue and Growth Rate of Cardiology 2016-2021

    • Figure Global Revenue and Growth Rate of Neurology 2016-2021

    • Figure Global Revenue and Growth Rate of Others 2016-2021

    • Table Global PET Radiopharmaceuticals Market Sales by Application (Historical)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Oncology 2016-2021

    • Figure Global Sales and Growth Rate of Cardiology 2016-2021

    • Figure Global Sales and Growth Rate of Neurology 2016-2021

    • Figure Global Sales and Growth Rate of Others 2016-2021

    • Table Global PET Radiopharmaceuticals Market Revenue by Application (Forecast)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Application (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales by Application (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Application (Forecast)

    • Table Global PET Radiopharmaceuticals Market Revenue by Geography (Historical)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Geography (Historical)

    • Figure Global PET Radiopharmaceuticals Revenue Market Share by Geography in 2020

    • Table Global PET Radiopharmaceuticals Market Sales by Geography (Historical)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Geography (Historical)

    • Figure Global PET Radiopharmaceuticals Sales Market Share by Geography in 2020

    • Table Global PET Radiopharmaceuticals Market Revenue by Geography (Forecast)

    • Table Global PET Radiopharmaceuticals Market Revenue Market Share by Geography (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales by Geography (Forecast)

    • Table Global PET Radiopharmaceuticals Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure North America PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table North America PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure North America PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure USA PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure USA PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Canada PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table North America PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table Europe PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure Europe PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure Germany PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Germany PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure France PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure France PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Italy PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Russia PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Spain PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Poland PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Austria PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table Europe PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table Asia PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure Asia PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure China PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure China PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Japan PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure India PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure India PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table Asia PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure South America PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table South America PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure South America PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure Brazil PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Chile PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table South America PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table Middle East PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table Middle East PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table Africa PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure Africa PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure Nigeria PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table Africa PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Revenue by Countries from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania PET Radiopharmaceuticals Revenue Market Share by Major Countries in 2020

    • Table Oceania PET Radiopharmaceuticals Sales by Countries from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania PET Radiopharmaceuticals Sales Market Share by Major Countries in 2020

    • Figure Australia PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Australia PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Value and Growth Rate from 2016 to 2026

    • Figure Others PET Radiopharmaceuticals Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Sales by Types from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Sales Market Share by Types from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Value by Types from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Value Market Share by Types from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Sales by Application from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Sales Market Share by Application from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Value by Application from 2016 to 2026

    • Table Oceania PET Radiopharmaceuticals Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of PET Radiopharmaceuticals

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of PET Radiopharmaceuticals with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.